$4.89
-0.13 (-2.59%)
Open$5.18
Previous Close$5.02
Day High$5.24
Day Low$4.64
52W High$9.10
52W Low$3.94
Volume—
Avg Volume17.9K
Market Cap55.85M
P/E Ratio—
EPS$-5.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+145.8% upside
Current
$4.89
$4.89
Target
$12.02
$12.02
$8.98
$12.02 avg
$15.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.76M | 4.74M | 44.29M |
| Net Income | -99,801,703 | -241,845,806 | 4.55M |
| Profit Margin | -5,668.6% | -5,385.2% | 10.3% |
| EBITDA | -105,750,014 | -270,496,804 | 9.89M |
| Free Cash Flow | — | — | 3.33M |
| Rev Growth | -62.9% | -62.9% | -0.9% |
| Debt/Equity | — | — | 0.50 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,168.88 | +0.34% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.65 | +0.07% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $151.72 | +1.48% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.87 | +0.47% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $73.00 | +2.34% | 11.5 | 30.15B |